Showing results (1-10 of 406) with videos related to
Sort By:
Pageof 41
Journal of Thrombosis and Haemostasis : JTH|September 24, 2021
Direct oral anticoagulant dose selection: Challenging casesStephanie Carlin, John W EikelboomCardiovascular Therapeutics|June 18, 2010
Apixaban in acute coronary syndromesGanesan Karthikeyan, John W EikelboomThrombosis and Haemostasis|November 3, 2006
Monitoring unfractionated heparin with the aPTT: time for a fresh lookJohn W Eikelboom, Jack HirshSeminars in Vascular Medicine|June 17, 2004
Antiplatelet agents in acute coronary syndromesJohn W Eikelboom, Sonia AnandDrugs|September 7, 2002
Management of patients with acute coronary syndromes: what is the clinical role of direct thrombin inhibitors?John W Eikelboom, John FrenchAnnals of Internal Medicine|October 2, 2023
In healthy older adults, low-dose aspirin increased incident anemia at a median 4.7 yStephanie Carlin, John W EikelboomAnnals of Internal Medicine|July 31, 2023
In DVT, oral DTIs and factor Xa inhibitors reduce major bleeding but not recurrent VTE vs. conventional anticoagulantsAlexander P Benz, John W EikelboomJournal of Thrombosis and Haemostasis : JTH|July 10, 2023
Warfarin faring better: vitamin K antagonists beat rivaroxaban and apixaban in the INVICTUS and PROACT Xa trialsJohn W Eikelboom, Jeffrey I WeitzAmerican Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|February 18, 2004
Failure of aspirin to prevent atherothrombosis: potential mechanisms and implications for clinical practiceJohn W Eikelboom, Graeme J HankeyFuture Cardiology|May 14, 2010
Point-of-care testing for assessment of adequacy of oral antiplatelet therapy in patients with cardiovascular diseaseMagdalena Sobieraj-Teague, John W EikelboomPageof 41